Research News at Hollings

Hollings smoking cessation expert determines benefits of early action to quit smoking after cancer diagnosis

a word cloud in the shape of an apple with Quit Smoking being the most prominent and other words including life, muscle and more

A study from Graham Warren, M.D., Ph.D., found that quitting smoking within six months after a cancer diagnosis adds an average of two years to a patient’s life. This reaffirms the broad survival benefit of using evidence-based smoking cessation to help patients quit as soon as possible.

“This is a survival benefit that we can achieve now. It isn't something that we need to wait 10 years for trial results,” he said.

Read about the study

cancer researcher Natalie Saini in her lab at Hollings Cancer Center

ACS Grant

MUSC Hollings Cancer Center researcher Dr. Natalie Saini was awarded a Research Scholar Grant by the American Cancer Society.

portrait of researcher Ashish Deshmukh in jacket and collared shirt open at the neck in a sunlit hallway

HPV Vaccine Success

Cervical cancer deaths in women under 25, who were tweens when the HPV vaccine was introduced, have plunged, Hollings researchers show.

image of a senior scientist and graduate student posing together in the cancer immunology research lab at Hollings Cancer Center

Golgi Stress

New research at Hollings shows how the Golgi body, an organelle within cells, could be a biomarker for T-cell tumor-fighting activity.
cancer and diabetes researcher Leo Ferreira in his lab at Hollings Cancer Center

Tregs to the Rescue

New research shows how Tregs could transform care for type 1 diabetes and eventually cancer and autoimmune diseases.

peering through shelving at a scientist in white coat and blue gloves concentrating on work in the lab

Catalyst Award

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Dr. Joe Delaney in his MUSC Hollings lab

Tackling Cancer Resistance

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.
cartoon illustration of a man laying down to enter a CT machine for a lung scan

Lung Cancer Screening

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

a scientist in a white lab coat sits at the bench next to a microscope with a computer screen showing the image

Identifying Targets

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

two women in business casual attire pose in a garden setting

Cannabis and Cancer

Cancer patients who smoke cigarettes are more likely than nonsmokers to use cannabis, researchers find.